Isabelle has over seven years of experience in market access consulting, specializing in policy and strategy for rare and innovative medicines. Her expertise spans above-asset policy shaping and product-level value communication and access strategy, bridging environmental factors with practical market access challenges.
Isabelle holds a Master’s degree in International Health policy from the London School of Economics and Political Science.